Cg Oncology Inc. logo

CGON

Cg Oncology Inc.

$35.51

Earnings Summary

Revenue
$0.53Mn
Net Profits
$-16.93Mn
Net Profit Margins
-3200.76%

Highlights

Revenue:

Cg Oncology Inc.’s revenue jumped 172.68% since last year same period to $0.53Mn in the Q1 2024. On a quarterly growth basis, Cg Oncology Inc. has generated 52800% jump in its revenue since last 3-months.

Net Profits:

Cg Oncology Inc.’s net profit fell -95.36% since last year same period to $-16.93Mn in the Q1 2024. On a quarterly growth basis, Cg Oncology Inc. has generated -5.06% fall in its net profits since last 3-months.

Net Profit Margins:

Cg Oncology Inc.’s net profit margin jumped 28.36% since last year same period to -3200.76% in the Q1 2024. On a quarterly growth basis, Cg Oncology Inc. has generated 99.8% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Cg Oncology Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-0.29
EPS Estimate Current Year
-0.29

Highlights

EPS Estimate Current Quarter:

Cg Oncology Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.29 - a 56.72% jump from last quarter’s estimates.

EPS Estimate Current Year:

Cg Oncology Inc.’s earning per share (EPS) estimates for the current year stand at -0.29.

Key Ratios

Key ratios of the Cg Oncology Inc. post its Q1 2024 earnings

Return on Assets (ROA)
0
Return on Equity (ROE)
0

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Cg Oncology Inc.’s return on assets (ROA) stands at 0.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Cg Oncology Inc.’s return on equity (ROE) stands at 0.